Robots & Robotics

WIRobotics Brings WIM S Walking Robot to U.S. Through Ottobock

WIRobotics has partnered with Ottobock to distribute its WIM S wearable walking robot in North America, starting with U.S. online sales and selected clinic trials.

By Laura Bennett | Edited by Daniel Krauss Published:
WIRobotics Brings WIM S Walking Robot to U.S. Through Ottobock
WIRobotics is expanding access to its WIM S wearable walking robot through a North American distribution agreement with Ottobock. Image: WIRobotics

Key Notes

  • WIRobotics and Ottobock have announced a North American distribution agreement for the WIM S wearable walking robot, with the launch beginning in the United States.
  • The 1.6 kg hip-worn device adds a consumer robotics product to online sales and selected in-person trial channels.
  • Canadian sales through the partnership and any future medical-product agreement remain separate next steps rather than completed launches.

WIRobotics is expanding U.S. distribution of its WIM S wearable walking robot through an agreement with Ottobock. The partnership connects the South Korean company’s hip-worn device with a mobility business that already has distribution, fitting and service networks in North America.

WIRobotics announced the arrangement on November 16. Its U.S. subsidiary signed the agreement on October 15. It covers the United States and Canada, with sales through the partnership beginning in the U.S.

A Wearable Robot Designed Around Walking

WIM S is worn at the waist and attaches to the thighs, applying assistance through the hips as the user walks. The manufacturer’s specifications list a weight of 1.6 kg, an integrated rechargeable battery and maximum torque of 6 Nm. A back-drivable mechanism is designed to allow movement while adding assistance.

The company’s U.S. overview describes modes for ordinary walking, inclines and resistance-based exercise, with an app for adjusting settings and viewing gait information. Those features make fitting and explanation part of the product experience: customers need to understand how assistance differs from resistance and how the device should sit on their body.

Online Sales Are Paired With In-Person Trials

The initial channels include Ottobock’s direct-to-consumer platform and WIRobotics USA’s online store. Consumers will also be able to try WIM S at selected orthotic and prosthetic clinics. The companies plan joint product training and after-sales support, giving the expansion a service component alongside product distribution.

WIRobotics says cumulative WIM-series sales have exceeded 4,000 units. That is a global series total, not a count of U.S. customers. More American trial locations and Canadian sales through this partnership will be considered based on customer feedback. The announcement does not disclose a purchase-volume commitment or financial terms.

Consumer Mobility and Medical Robotics Follow Separate Paths

The agreement concerns WIM S. The partners also see potential for WIM Medi, a version in development for medical use, but say that entering medical and rehabilitation channels would require applicable regulatory authorization and a separate agreement. The current distribution deal does not establish approval or treatment outcomes for that future product.

Our reporting on Hyundai’s rehabilitation work examines a different route into wearable robotics, where supervised clinical applications have their own validation requirements. WIRobotics also participates in South Korea’s broader robotics development program. For WIM S, the immediate commercial step is more concrete: letting American consumers encounter, fit and obtain support for a wearable robot through established channels.

Disclaimer: RobotsBeat is an independent media brand owned and operated by NuvexMedia LLC, publishing news, research, and insights on artificial intelligence, emerging technologies, automation, and related industries. NuvexMedia LLC invests in and collaborates with companies across the AI, Robotics, technology, software, and digital innovation sectors. These relationships do not influence RobotsBeat's editorial coverage, and the publication maintains full editorial independence to provide accurate, timely, and objective information. © 2026 NuvexMedia LLC. All rights reserved. This content is for informational purposes only and should not be considered legal, tax, investment, financial, or other professional advice.

Business & Markets, News, Robots & Robotics